Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bernhard Tewes
Observed names:
B Tewes,
B. Tewes,
Tewes, Bernhard
Institution:
Dr Falk Pharma (Germany)
Observed institution:
Dr Falk Pharma (Germany)
OpenAlex ID:
A5049029240
Trichuris suis and Trichuris trichiura are different nematode species
2009
·
C. Cutillas
, R. Callejón
, et al.
·
Acta Tropica
·
114
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease
2024
·
Valeriia Dotsenko
, Bernhard Tewes
, et al.
·
Nature Immunology
·
60
Assessment of drug–drug interaction for silymarin
2008
·
Johannes Doehmer
, Bernhard Tewes
, et al.
·
Toxicology in Vitro
·
41
Preventive Trichuris suis ova (TSO) treatment protects immunocompetent rabbits from DSS colitis but may be detrimental under conditions of immunosuppression
2017
·
Irina Leonardi
, Alexandra Gerstgrasser
, et al.
·
Scientific Reports
·
23
PDF
Su1161 - The Oral Transglutaminase 2 (TG2) Inhibitor Zed1227 Blocks TG2 Activity in a Mouse Model of Intestinal Inflammation
2018
·
Manuel A. Encalada Ventura
, Kaja Sajko
, et al.
·
Gastroenterology
·
18
Oral administration of dextran sodium sulphate induces a caecum‐localized colitis in rabbits
2015
·
Irina Leonardi
, Flora Nicholls
, et al.
·
International Journal of Experimental Pathology
·
16
Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Valeriia Dotsenko
, Hana Hien Le
, et al.
·
BMC Medicine
·
2
245 the Oral Tissue Transglutaminase Inhibitor Zed1227 Prevents Gluten-induced Enteropathy in a Transgenic Mouse Model of Celiac Disease
2021
·
Manuel A. Encalada Ventura
, Martin Hils
, et al.
·
Gastroenterology
·
1
Glucuronidation directs systemically available norursodeoxcholic acid (norUDCA) to the kidney
2020
·
Emina Halilbasic
, Michael Trauner
, et al.
·
Journal of Hepatology
·
1
A Humanized Celiac Disease Mouse Model Reflects Histologic and Immune Effects of Transglutaminase Inhibition in Patients
2026
·
Aline Pesi
, Manuel A. Encalada-Ventura
, et al.
·
Gastroenterology
1098 Tg2 Inhibition During Gluten Reintroduction Skews Duodenal Immunometabolism Toward Omega-3/linoleic Pathways and Ferroptosis Control in Celiac Disease
2026
·
Aline Pesi
, Valeriia Dotsenko
, et al.
·
Gastrointestinal Endoscopy
1098 Tg2 Inhibition During Gluten Reintroduction Skews Duodenal Immunometabolism Toward Omega-3/linoleic Pathways and Ferroptosis Control in Celiac Disease
2026
·
Aline Pesi
, Valeriia Dotsenko
, et al.
·
Gastroenterology
Additional file 4 of Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Dotsenko, Valeriia
, Le, Hana Hien
, et al.
·
Figshare
Additional file 5 of Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Dotsenko, Valeriia
, Le, Hana Hien
, et al.
·
Figshare
Additional file 2 of Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Dotsenko, Valeriia
, Le, Hana Hien
, et al.
·
Figshare
Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Dotsenko, Valeriia
, Le, Hana Hien
, et al.
·
Figshare
Additional file 1 of Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Dotsenko, Valeriia
, Le, Hana Hien
, et al.
·
Figshare
Additional file 3 of Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
2026
·
Dotsenko, Valeriia
, Le, Hana Hien
, et al.
·
Figshare
Regulatorische Immunzellen modulieren die intestinale Immunantwort bei Glutenprovokation in der Zöliakie – Wirkung des TG2-Inhibitors Zed1227: Ergebnisse der klinischen CEC-3 Studie
2025
·
A Pesi
, V Dotsenko
, et al.
·
Zeitschrift für Gastroenterologie
The Oral Tissue Transglutaminase Inhibitor Zed1227 Prevents Gluten-Induced Enteropathy In A Humanized Mouse Model Of Celiac Disease
2022
·
M Encalada
, H El Mard
, et al.
·
Zeitschrift für Gastroenterologie
Ci3-Verbundprojekt: Transglutaminase-Inhibitoren zur Behandlung der Zöliakie (KETI-2) : Schlussbericht : Teilprojekt Falk Pharma: Prozessentwicklung Wirkstoffsynthese und präklinische Entwicklung : Laufzeit des Vorhabens 01.10.2015-31.03.2017
2017
·
Greinwald, Roland
, Tewes, Bernhard
, et al.
·
TIB Hannover
Effekte der akuten Gabe von Udenafil auf den Pfortaderdruck bei Ratten mit Leberzirrhose
2015
·
FE Uschner
, S Klein
, et al.
·
Zeitschrift für Gastroenterologie
Poster Abstracts
2003
·
Ralf Littger
, Alexandra Alke
, et al.
·
Journal of Liposome Research
Show more works
View as search
Works count:
23
Citation count:
276
H-index:
6
I10-index:
6
Year
Topic
Type
